GlobeNewsWire
22 Sept 2026, 21:43 UTC · 1h ago
Verdict
Headline takes no side. We score CAPR −1.00 across two claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
Capricor Therapeutics is facing a class action lawsuit alleging it failed to disclose that the FDA had not agreed to changes in the statistical analysis plan for Deramiocel before the BLA resubmission.
Priced inlawsuit has already been filed
More negative than 95% of claims this week
The lead plaintiff deadline for the securities class action regarding purchases between December 17, 2025 and July 26, 2026 is September 28, 2026.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
So whatThe determination of the lead plaintiff within the next 6 days will set the legal strategy and potential settlement scale for the litigation.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities class action lawsuit alleging misleading statements regarding FDA clinical data for Deramiocel.
More negative than 87% of ticker scores this week
The company is mentioned as the subject of a reminder for a securities class action lawsuit.
More negative than 87% of ticker scores this week
The company is mentioned as the subject of a reminder for a securities class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
—
CAPR hasn't traded since this ran. Last close $9.34 (Sep 22); the reaction starts at the next open.
CAPR chart →